Registry-listed formulations

This catalogue entry has no confirmed scientific concept.

Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.

0 source entries across 0 studies. This list may not include all unresolved or historical entries.

    Success Metrics

    Clinical Success Rate
    100.0%

    Based on 1 completed trials

    Completion Rate
    100%(1/1)
    Active Trials
    2(50%)
    Results Posted
    100%(1 trials)

    Phase Distribution

    Phase 1
    2
    50%
    Not Applicable
    2
    50%

    Phase Distribution

    2

    Early Stage

    0

    Mid Stage

    0

    Late Stage

    Phase Distribution4 total trials
    Phase 1Safety & dosage
    2(50.0%)
    N/ANon-phased studies
    2(50.0%)

    Highest Phase Reached

    Phase 1

    Trial Status & Enrollment

    Completion Rate

    100.0%

    1 of 1 finished

    Non-Completion Rate

    0.0%

    0 ended early

    Currently Active

    2

    trials recruiting

    Total Trials

    4

    all time

    Status Distribution
    Active(2)
    Completed(1)
    Other(1)

    Detailed Status

    Active, not recruiting1
    unknown1
    Completed1
    Recruiting1

    Development Timeline

    Analytics

    Development Status

    Total Trials
    4
    Active
    2
    Success Rate
    100.0%
    Most Advanced
    Phase 1

    Trials by Phase

    Phase 12 (50.0%)
    N/A2 (50.0%)

    Trials by Status

    active_not_recruiting125%
    unknown125%
    completed125%
    recruiting125%

    Recent Activity

    2 active trials
    Showing 4 of 4
    recruitingnot_applicable

    ID93/GLA-SE Vaccination + BCG Challenge

    NCT06670755
    active_not_recruitingnot_applicable

    BCG Revaccination Study in Diabetic and Non-Diabetic Adults

    NCT06246851
    completedphase_1

    Aerosol BCG Challenge Study in Historically BCG-vaccinated Volunteers

    NCT04777721
    unknownphase_1

    Investigating Immune Responses to Aerosol BCG Challenge in Healthy UK Adults

    NCT03912207

    Clinical Trials (4)

    Showing 4 of 4 trials
    NCT06670755Not Applicable

    ID93/GLA-SE Vaccination + BCG Challenge

    Recruiting
    NCT06246851Not Applicable

    BCG Revaccination Study in Diabetic and Non-Diabetic Adults

    Active Not Recruiting
    NCT04777721Phase 1

    Aerosol BCG Challenge Study in Historically BCG-vaccinated Volunteers

    Completed
    NCT03912207Phase 1

    Investigating Immune Responses to Aerosol BCG Challenge in Healthy UK Adults

    Unknown

    All 4 trials loaded

    Drug Details

    Intervention Type
    Biological
    Total Trials
    4